XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net income $ 97,029 $ 92,380
Adjustments to reconcile net income to net cash flows from operating activities:    
Provision for credit losses on accounts receivable 1,399 530
Reserve for product returns 2,444 2,672
Provision for credit losses on notes receivable 748 3,996
Amortization on patents and tooling 542 657
Amortization and depreciation 22,351 22,029
Amortization of debt issuance costs 4,513 3,296
Amortization of operating leases 11,657 9,425
Deferred income taxes 18,713 (32,739)
Change in fair value of contingent liability 252 105
Stock-based compensation 26,613 31,675
Distributions on investments in unconsolidated entities 4,014 0
(Gain on) / loss from investments in unconsolidated entities (3,077) 203
Changes in operating assets and liabilities (net of business acquisitions):    
Accounts receivable 11,645 6,425
Inventory (3,485) 21,195
Other current and non-current assets (19,858) (5,034)
Accounts payable and other current liabilities (48,290) (4,904)
Deferred revenue 1,404 4,126
Operating lease liabilities (9,884) (9,171)
Other liabilities (1,329) 3,287
Cash flows from operating activities 117,401 150,153
Cash flows used in investing activities:    
Business acquisition, net of cash acquired (35,733) 0
Additions to property and equipment (15,421) (7,865)
Issuances of notes receivable (24,305) (500)
Receipt of payments on notes receivable 86 38
Capitalized software development costs (1,032) (1,128)
Proceeds from sale of investments in unconsolidated entities 1,459 0
Purchase of investments in unconsolidated entities (175,057) (7,052)
Purchases of other intangible assets 0 (46)
Cash flows used in investing activities (250,003) (16,553)
Cash flows (used in) / from financing activities:    
Proceeds from issuance of convertible senior notes 0 500,000
Payments of debt issuance costs 0 (14,834)
Purchases of capped calls related to convertible senior notes 0 (63,050)
Payments of deferred consideration for acquisitions (1,741) (7,269)
Purchases of treasury stock, including transaction costs (22,419) (75,000)
Payments of tax withholdings related to vesting of restricted stock units 0 (3,401)
Purchases of redeemable noncontrolling interest (750) 0
Issuances of common stock from equity-based plans 3,440 7,840
Cash flows (used in) / from financing activities (21,470) 344,286
Effect of exchange rate changes on cash, cash equivalents and restricted cash (161) (290)
Net (decrease) / increase in cash, cash equivalents and restricted cash (154,233) 477,596
Cash, cash equivalents and restricted cash at beginning of the period 1,229,132 701,079
Cash, cash equivalents and restricted cash at end of the period 1,074,899 1,178,675
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 1,066,583 1,170,605
Restricted cash included in other current assets and other assets 8,316 8,070
Total cash, cash equivalents and restricted cash $ 1,074,899 $ 1,178,675